FDA NDC Directory · JSON-LD · Markdown

Liraglutide

NDC 0480-7250 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Labeler / ManufacturerTeva Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA214568
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsLIRAGLUTIDE (6 mg/mL)
Marketing started20250828
Marketing ended20270930
Package count1

External sources

Source: openFDA. Public-domain (CC0).